Sunday, November 8, 2026
TGOs

The business of defense

Get the Weekly
Topics
Menu
Search

Company

GlaxoSmithKline

GSK is a British pharmaceutical and biotechnology company that prevents and treats disease with specialty medicines, vaccines and general medicines. ↗

HeadquartersLondon, England ↗
Founded2000 ↗
LeadershipLuke Miels, CEO ↗
Employees66,800 ↗
Department of War obligations$1.6 billion in prime contracts since fiscal 2022 ↗
OwnershipPublic ↗; ViiV Healthcare (76.5%) ↗
SharesGSK, GLAXF ↗
Websitewww.gsk.com ↗

Products

  • Shingrix is GSK's shingles (zoster) vaccine. ↗
  • Arexvy is GSK's respiratory syncytial virus (RSV) vaccine. ↗
  • GSK developed RTS,S, the first malaria vaccine. ↗

Acquisitions

  • GSK acquired Tesaro, an oncology company, in 2019. ↗
  • GSK acquired Sierra Oncology in 2022. ↗
  • GSK acquired Affinivax in 2022. ↗
  • GSK acquired Bellus Health in 2023. ↗
  • GSK acquired Aiolos Bio in 2024. ↗

Segments

  • GSK sells specialty medicines, vaccines and general medicines. ↗